General Electric (NYSE:GE) Submits Healthcare Module

XCSFDHG46767FHJHJF

tdp2664 E money daily General Electric (NYSE:GE) healthcare has submitted the first module of its premarket approval application. General Electric (NYSE:GE) Submits Healthcare Module The US based company General Electric (NYSE:GE) has said that it recently presented to the U.S. food and drug administration the first unit of its premarket approval application for General Electric (NYSE:GE) Breast Tomosynthesis, a choice of the Senographe essential method. Anne LeGrand, General Electric (NYSE:GE) Healthcare's vice president and general manager of the company's global X-ray business, said that, "Worldwide, more than 1.2 million people annually are diagnosed with breast cancer. Since 1965, General Electric (NYSE:GE) Healthcare has made significant progress in providing solutions for breast cancer detection and diagnosis that really bring a change to people's lives. Today through 'healthymagination', we continuously develop innovations to reduce costs, increase access and improve quality and efficiency of healthcare delivery around the globe." General Electric Co. (NYSE:GE) company shares are currently standing at 16.06. Price History Last Price: 16.06 52 Week Low / High: 14.02 / 21.65 50 Day Moving Average: 15.97 6 Month Price Change %: -21.1% 12 Month Price Change %: -4.6%